secwatch.observer — SEC 8-K summary
======================================

Issuer:     DYADIC INTERNATIONAL INC (DYAI)
CIK:        0001213809
Form:       8-K
Filed at:   2021-11-09T23:59:59+00:00
Accession:  0001437749-21-025790
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dyadic appoints Joseph Hazelton as Chief Business Officer; base salary $240k, option grant of 75k shares
--------------------------------------------------------------------------------

- Joseph Hazelton appointed CBO effective Nov 9, 2021; reports to CEO Mark Emalfarb.
- Annual base salary $240k; eligible for cash bonus up to 30% of base.
- Received option to purchase 75k shares at Nov 9 closing price; vests upon $10M in non-refundable cash from transactions he initiated within 3 years.
- Over 20 years pharma experience; previously COO/CCO at Charleston Labs, 15 years at Novartis.
- Press release issued Nov 9, 2021 announcing the appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1213809/000143774921025790/0001437749-21-025790-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1213809/000143774921025790/dyai20211105_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-21-025790

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer